United Therapeutics (UTHR) Tax Provisions (2009 - 2026)

United Therapeutics has disclosed Tax Provisions across 18 years of filings, most recently posting $39.7 million for Q2 2026.

• In Q2 2026, Tax Provisions fell 59.86% year-over-year to $39.7 million; the TTM figure through Jun 2026 stood at $262.1 million (down 30.09% YoY), while the FY2025 annual figure was $379.2 million, up 10.26% from the prior year.
• Tax Provisions came in at $39.7 million for Q2 2026 at United Therapeutics, down from $43.4 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $101.3 million in Q1 2025 to a low of $34.6 million in Q2 2022.
• Average Tax Provisions over 5 years is $73.3 million, with a median of $77.8 million recorded in 2023.
• Year-over-year, Tax Provisions soared 1538.1% in 2022 and plunged 59.86% in 2026.
• Over 5 years, Tax Provisions stood at $46.7 million in 2022, then jumped by 67.67% to $78.3 million in 2023, then climbed by 21.58% to $95.2 million in 2024, then decreased by 16.28% to $79.7 million in 2025, then plunged by 50.19% to $39.7 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $39.7 million in Q2 2026, $43.4 million in Q1 2026, and $79.7 million in Q4 2025.